[The semi-quantitative method for evaluating lipid accumulation in pancreas of diabetic mice]

Yao Xue Xue Bao. 2011 Jun;46(6):664-8.
[Article in Chinese]

Abstract

To investigate the semi-quantitative method for evaluating the lipid accumulation in pancreas, the KKAy mice, a classical type 2 diabetes mellitus model mice, were used and treated with rosiglitazone (Rosi); and the age-matched C57BL/6J mice were used as normal control. Pancreas was fixed quickly for histological examination with HE staining. For the estimation of the lipid accumulation in pancreas, semi-quantitative method was designed: the number and the size of islet, lipid accumulation in islet and in exocrine gland were observed and the integrative score calculated under the microscope, separately. In KKAy mice, the characteristics of the increased amount of islet, the enlarged area of islet, an abundance of large vacuolations, lipid droplets, and fat proliferation were exposed frequently, and the integrative score increased 2.1 folds compared with that in C57BL/6J mice. Meanwhile, the levels of serum glucose, insulin, and triglyceride (TG) were 1.7, 18.0, and 9.0 times as those in C57BL/6J mice, respectively. With the rosiglitazone (10 mg x kg(-1)) treatment, compared with that in KKAy mice, the pancreatic pathological changes were ameliorated significantly, and the integrative score in KKAy + Rosi mice decreased by 28.9%; and the levels of serum glucose, insulin, and triglyceride decreased by 48.3%, 81.3% and 64.1%, respectively. It showed there is a correlation between the pancreatic pathological semi-quantitative score and the values of serum parameters. In conclusion, this semi-quantitative scoring method is simple and objective for the evaluation of lipid accumulation in pancreas of mice.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Glucose / metabolism
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / metabolism
  • Diabetes Mellitus, Type 2 / pathology*
  • Female
  • Hypoglycemic Agents / pharmacology*
  • Insulin / blood
  • Islets of Langerhans / metabolism
  • Islets of Langerhans / pathology
  • Lipid Metabolism / drug effects*
  • Mice
  • Mice, Inbred C57BL
  • Pancreas / metabolism
  • Pancreas / pathology*
  • Random Allocation
  • Rosiglitazone
  • Thiazolidinediones / pharmacology*
  • Triglycerides / blood

Substances

  • Blood Glucose
  • Hypoglycemic Agents
  • Insulin
  • Thiazolidinediones
  • Triglycerides
  • Rosiglitazone